Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split vs standard cisplatin with radiotherapy in HNSCC
NCT03330249Phase 2Completed
- Sponsor
- GORTEC
- Start
- Dec 2015
- Primary completion
- May 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in squamous cell carcinoma of the head and neck (HNSCC), sponsored by GORTEC. Started Dec 2015; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT03330249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03330249.